CXCL3 and cervical carcinoma: Based on available findings that the involvement of CXCL3 depletion in the anticancer mechanism of solamargine might be entwined with the depression of the Erk signaling pathway, we applied PD98059 to block Erk1/2 in cervical cancer cells in a follow-up study and obtained more intuitive results.